SkyOak Wealth’s Transmedics TMDX Stock Holding History

SkyOak Wealth’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,614	Closed	-$243K	–	264
2024 Q2	$243K	Buy	+1,614	New	+$194K	0.06%	203

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

SkyOak Wealth's TMDX Position: Q3 2024 in Review

SkyOak Wealth sold out of Transmedics (TMDX) in Q3 2024, closing a stake of 1,614 shares — an estimated $243K sold.

SkyOak Wealth first reported a position in TMDX in Q2 2024 and held it in 1 quarter. The position peaked at $243K in Q2 2024. 373 funds tracked by Wall St. Rank hold TMDX as of Q3 2024.

SkyOak Wealth reported no remaining Transmedics position as of Q3 2024 after selling out during the quarter.
SkyOak Wealth sold 1,614 Transmedics shares in Q3 2024, an estimated $243K.
SkyOak Wealth first reported a position in Transmedics in Q2 2024 and held it in 1 quarter.
SkyOak Wealth's Transmedics position peaked at $243K in Q2 2024.
373 funds tracked by Wall St. Rank held Transmedics as of Q3 2024.

Based on SkyOak Wealth's 13F filing for Q3 2024, filed 4 Nov 2024.